FCA
IDXX icon

Fortis Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

Fortis Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,700
Closed -$818K – 275
2024
Q4 		$818K Buy
+1,700
New +$746K 0.28% 75
2024
Q3 		– Sell
-1,827
Closed -$890K – 188
2024
Q2 		$890K Buy
+1,827
New +$917K 0.32% 62
2023
Q2 		– Sell
-100
Closed -$50K – 347
2023
Q1 		$50K Hold
100
– – 0.03% 284
2022
Q4 		$40.8K Buy
+100
New +$38.8K 0.02% 319

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Fortis Capital Advisors's IDXX Position: Q1 2025 in Review

Fortis Capital Advisors sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 1,700 shares — an estimated $818K sold.

Fortis Capital Advisors first reported a position in IDXX in Q4 2022 and held it in 4 quarters. The position peaked at $890K in Q2 2024. 1,144 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • Fortis Capital Advisors reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
  • Fortis Capital Advisors sold 1,700 Idexx Laboratories shares in Q1 2025, an estimated $818K.
  • Fortis Capital Advisors first reported a position in Idexx Laboratories in Q4 2022 and held it in 4 quarters.
  • Fortis Capital Advisors's Idexx Laboratories position peaked at $890K in Q2 2024.
  • 1,144 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Fortis Capital Advisors's 13F filing for Q1 2025, filed 20 May 2025.